AJSM
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
First published on August 16, 2004, doi:10.1177/0363546503262806
This version was published on October 1, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
32/7/1660    most recent
0363546503262806v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chung, B.
Right arrow Articles by Wiley, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, B.
Right arrow Articles by Wiley, J. P.
Related Collections
Right arrow Elbow
Right arrow Nonoperative
The American Journal of Sports Medicine 32:1660-1667 (2004)
© 2004 American Orthopaedic Society for Sports Medicine

Effectiveness of Extracorporeal Shock Wave Therapy in the Treatment of Previously Untreated Lateral Epicondylitis

A Randomized Controlled Trial

Bryan Chung* and J. Preston Wiley, MD*,{dagger}

From the * University of Calgary Sport Medicine Centre, Faculty of Kinesiology, Calgary, Alberta, Canada

{dagger} Address correspondence to J. Preston Wiley, MD, University of Calgary Sport Medicine Centre, 2500 University Drive NW, Calgary, AB, Canada T2N 1N4 (e-mail: wiley{at}ucalgary.ca).

Background: Extracorporeal shock wave therapy is a relatively new therapy used in the treatment of chronic tendon-related pain. Few randomized controlled trials have been performed on it, and no studies have examined the effectiveness of extracorporeal shock wave therapy as a frontline therapy for tendon-related pain.

Hypothesis: Subjects treated with active extracorporeal shock wave therapy will have higher rates of treatment success than subjects treated with sham extracorporeal shock wave therapy.

Design: Double-blind randomized controlled trial.

Methods: Sixty subjects who had previously untreated lateral epicondylitis for less than 1 year and more than 3 weeks were included in this study. Subjects were randomly allocated to receive 1 session per week for 3 weeks of either sham or active extra-corporeal shock wave therapy. Subjects in the active therapy group received 2000 pulses (energy flux density, 0.03–0.17 mJ/mm2). All subjects were provided with a forearm-stretching program. After 8 weeks of therapy, subjects were classified as either treatment successes or treatment failures according to fulfillment of all 3 criteria: (1) at least a 50% reduction in the overall pain visual analog scale score, (2) a maximum allowable overall pain visual analog scale score of 4.0 cm, and (3) no use of pain medication for elbow pain for 2 weeks before the 8 week follow-up. Visual analog scale scores were also collected for pain at rest, during sleep, during activity, at its worst, and at its least, as well as for quality of life (using the EuroQoL questionnaire) and grip strength.

Results: Success rates in the sham and active therapy groups were 31% and 39%, respectively. No significant difference was detected between groups ({chi}21= 0.3880, P = .533). Mean change in quality of life over 8 weeks was an increase of 1.3 and 3.3 for sham and active therapy groups, respectively, and mean change in grip strength over 8 weeks was an increase of 7.4 kg and 6.8 kg for sham and active therapy groups, respectively.

Conclusions: Despite improvement in pain scores and pain-free maximum grip strength within groups, there does not appear to be a meaningful difference between treating lateral epicondylitis with extracorporeal shock wave therapy combined with forearm-stretching program and treating with forearm-stretching program alone, with respect to resolving pain within an 8-week period of commencing treatment.

Key Words: lateral epicondylitis • randomized controlled trial • extracorporeal shock wave therapy (ESWT)




This article has been cited by other articles:


Home page
Clin RehabilHome page
M. Reza Nourbakhsh and F. J Fearon
An alternative approach to treating lateral epicondylitis. A randomized, placebo-controlled, double-blinded study
Clinical Rehabilitation, July 1, 2008; 22(7): 601 - 609.
[Abstract] [PDF]


Home page
Br Med BullHome page
J. D. Rompe and N. Maffulli
Repetitive shock wave therapy for lateral elbow tendinopathy (tennis elbow): a systematic and qualitative analysis
Br. Med. Bull., September 1, 2007; 83(1): 355 - 378.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
J. Cowan, S. Lozano-Calderon, and D. Ring
Quality of Prospective Controlled Randomized Trials. Analysis of Trials of Treatment for Lateral Epicondylitis as an Example
J. Bone Joint Surg. Am., August 1, 2007; 89(8): 1693 - 1699.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
F. A. Pettrone and B. R. McCall
Extracorporeal Shock Wave Therapy without Local Anesthesia for Chronic Lateral Epicondylitis
J. Bone Joint Surg. Am., June 1, 2005; 87(6): 1297 - 1304.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
Evidence based journal watch
Br. J. Sports Med., May 1, 2005; 39(5): 309 - 310.
[Full Text] [PDF]


Home page
Am J Sports MedHome page
J. D. Rompe, B. Chung, and P. Wiley
Letters to the Editor * Authors' Response
Am. J. Sports Med., March 1, 2005; 33(3): 461 - 463.
[Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, November 27, 2004; 329(7477): 1296 - 1296.
[Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Orthopaedic Society for Sports Medicine.